entertainment -WSS

entertainment

author：entertainment 2025-09-27 09:55:05 - browse：8

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： SCOTUS questions limit to govt efforts to fight misinformation

entertainment

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

Diagnostic tests are hitting their mathematical limits

FDA investigates CAR

Colonoscopy prep: Liquid

The EPA's new lead rule: How one expert crunched the numbers

UnitedHealth’s Optum accused of antitrust violations in California

leisure time

entertainment

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What don’t we know about an Alzheimer’s drug side effect?

In age of alternative facts, a scholarly course on calling out crap

U.K. Biobank has 500,000 peoples' genome sequences available

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Creating egg and sperm cells from stem cells raises ethical issues

New air purifier tech could be key to improving indoor air quality

UnitedHealth’s Optum accused of antitrust violations in California

Jerome Adams on the need for new antivirals for Covid

Baby aspirin cuts fat buildup in liver disease patients, in small study

entertainment

Nurses recount patients attacks

Takeda, Janssen join wearable maker to measure scratching

Readout Newsletter: Bluebird, CVS, Contineum

Asbestos, a deadly carcinogen, banned by EPA

The EPA's new lead rule: How one expert crunched the numbers

Positive childhood experiences can help future health

entertainment

explore

hotspot

knowledge